A national sample of individuals who acquired hepatitis C virus infections in childhood or adolescence: Risk factors for advanced disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 3, 2007, Pages 335-341

  Harris, Helen E ^a   Mieli Vergani, Giorgina ^b   Kelly, Deirdre ^c   Davison, Suzanne ^d   Gibb, Diana M ^e   Ramsay, Mary E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Hepatitis C virus; Natural history; Risk factors

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; LIVER; LOGISTIC MODELS; MALE; ODDS RATIO; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 34548684113     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3180dc9337     Document Type: Article

References (21)

1. Jonas MM. Children with hepatitis C. Hepatology 2002;36 (Suppl): S173-8.
2. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003;70:373-7.
3. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004;39:90-6.
4. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003;36:275-80.
5. Harris HE, Ramsay ME, Andrews N, et al. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002;324:450-3.
6. Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.
7. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001;33:455-63.
8. Bortolotti F, Iorio R, Resti M, et al. An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999. J Pediatr Gastroenterol Nutr 2001;32:562-6.
9. Harris HE, Ramsay ME, Heptonstall J, et al. The HCV National Register: towards informing the natural history of hepatitis C infection in the UK. J Viral Hepatol 2000;7:420-7.
10. The HCV Lookback Collation Collaborators. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV Lookback Programme. Transfusion 2002;42:1146-53.
11. Gibb DM, Neave PE, Tookey PA, et al. Active surveillance of hepatitis C infection in the UK and Ireland. Arch Dis Child 2000;82:286-91.
12. Goldin RD, Goldin JG, Burt AD, et al. Intra-observer and interobserver variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996;25:649-54.
13. Westin J, Lagging LM, Wejstal R, et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999;19:183-7.
14. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
15. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
16. Iorio R, Giannattasio A, Sepe A, et al. Chronic hepatitis C in childhood. Clin Infect Dis 2005;41:1431-7.
17. Murray KF, Finn LS, Taylor SL, et al. Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr 2005;41:634-8.
18. Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997;26:1393-8.
19. Dincer D, Okten A, Kaymakoglu S, et al. Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us? Hepatogastroenterology 2001;48:1397-400.
20. Gonzalez-Peralta RP, Kelly DA, Haber B, et al. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 2005;42:1010-8.
21. Jonas MM, Ott MJ, Nelson SP, et al. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J 1998;17:241-6.